Hepatitis C Virus
Intravenous drug abuse associated with high risk of HIV/HCV coinfection
Published in AIDS Weekly, August 16th, 2004
"The purpose of this study was to determine the prevalence and incidence of HIV and hepatitis C virus (HCV) coinfection among young (aged 29 years or younger) injection drug users (IDUs) and to compare sociodemographic and risk characteristics between (HIV/HCV) coinfected, monoinfected, or HIV- and HCV-negative youth.
"Data were collected through the Vancouver Injection Drug Users Study (VIDUS). To date, more than 1400 IDUs have been enrolled and followed, of whom 479 were aged 29 years or younger," investigators in Canada report.
"Semiannually,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-08-16)
More Articles from AIDS Weekly
- Antiretroviral Drug Resistance
Long-term suppression of HIV RNA with HAART occur despite virus evolution - Antiretroviral Therapy
Addition of tenofovir decreases AUC for atazanavir in HIV-treated patients - HIV/AIDS Research
New generation of SNV-based vectors may be used to block HIV-1 replication - HIV/AIDS Screening
Use of two HIV antibody screening tests increase false-positive rate - Perinatal HIV/AIDS
Rapid HIV testing during labor links HIV-positive pregnant women to treatment - AIDS/HIV Diagnosis
Performance of rapid HIV antibody detection assays evaluated - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
